Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pyrazinamide 600mg/5ml oral liquid
0501090N0AABPBP
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 625mg/5ml oral liquid
0501090N0AABSBS
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 650mg/5ml oral liquid
0501090N0AACACA
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 675mg/5ml oral liquid
0501090N0AABQBQ
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 700mg/5ml oral liquid
0501090N0AACCCC
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 750mg/5ml oral liquid
0501090N0AAA8A8
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 75mg/5ml oral liquid
0501090N0AABLBL
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 850mg/5ml oral liquid
0501090N0AABWBW
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 91mg/5ml oral liquid
0501090N0AACGCG
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.